Neuromelanin and selective neuronal vulnerability to Parkinson’s disease

dc.contributor
Institut Català de la Salut
dc.contributor
[Filimontseva A, Fu Y, Halliday GM] Brain and Mind Centre & Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, USA. [Vila M] Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, USA. Grup de Recerca de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. Department of Biochemistry and Molecular Biology, Institute of Neuroscience, Autonomous University of Barcelona, Bellaterra, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Filimontseva, Anastasia
dc.contributor.author
Fu, YuHong
dc.contributor.author
Vila, Miquel
dc.contributor.author
Halliday, Glenda
dc.date.accessioned
2025-10-24T08:57:31Z
dc.date.available
2025-10-24T08:57:31Z
dc.date.issued
2025-07-07T06:55:03Z
dc.date.issued
2025-07-07T06:55:03Z
dc.date.issued
2025-06
dc.identifier
Filimontseva A, Fu Y, Vila M, Halliday GM. Neuromelanin and selective neuronal vulnerability to Parkinson’s disease. Trends Neurosci. 2025 Jun;48(6):445-59.
dc.identifier
1878-108X
dc.identifier
http://hdl.handle.net/11351/13358
dc.identifier
10.1016/j.tins.2025.04.005
dc.identifier
40335409
dc.identifier.uri
http://hdl.handle.net/11351/13358
dc.description.abstract
Aging; Neurodegeneration; Substantia nigra
dc.description.abstract
Envelliment; Neurodegeneració; Substància negra
dc.description.abstract
Envejecimiento; Neurodegeneración; Sustancia negra
dc.description.abstract
Neuromelanin is a unique pigment made by some human catecholamine neurons. These neurons survive with their neuromelanin content for a lifetime but can also be affected by age-related neurodegenerative conditions, as observed using new neuromelanin imaging techniques. The limited quantities of neuromelanin has made understanding its normal biology difficult, but recent rodent and primate models, as well as omics studies, have confirmed its importance for selective neuronal loss in Parkinson’s disease (PD). We review the development of neuromelanin in dopamine versus noradrenaline neurons and focus on previously overlooked cellular organelles in neuromelanin formation and function. We discuss the role of neuromelanin in stimulating endogenous α-synuclein misfolding in PD which renders neuromelanin granules vulnerable, and can exacerbates other pathogenic processes.
dc.description.abstract
This work was supported in part by Aligning Science Across Parkinson’s [020505] through the Michael J. Fox Foundation for Parkinson’s Research (MJFF) and also by funding to GH from the National Health and Medical Research Council of Australia [Investigator Grant 1176607]. For open access, the authors have applied a CC BY public copyright license to all Author Accepted Manuscripts arising from this submission. We would like to thank Heidi Cartwright for assistance with the figures.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier
dc.relation
Trends in Neurosciences;48(6)
dc.relation
https://doi.org/10.1016/j.tins.2025.04.005
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Scientia
dc.subject
Parkinson, Malaltia de
dc.subject
Neurones dopaminèrgiques
dc.subject
DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Basal Ganglia Diseases::Parkinsonian Disorders::Parkinson Disease
dc.subject
CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Amino Acids::Amino Acids, Cyclic::Amino Acids, Aromatic::Tyrosine::Melanins
dc.subject
ANATOMY::Nervous System::Neurons::Dopaminergic Neurons
dc.subject
CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Nerve Tissue Proteins::Synucleins::alpha-Synuclein
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::enfermedades de los ganglios basales::trastornos parkinsonianos::enfermedad de Parkinson
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::aminoácidos::aminoácidos cíclicos::aminoácidos aromáticos::tirosina::melaninas
dc.subject
ANATOMÍA::sistema nervioso::neuronas::neuronas dopaminérgicas
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas del tejido nervioso::sinucleínas::alfa-sinucleína
dc.title
Neuromelanin and selective neuronal vulnerability to Parkinson’s disease
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)